Further studies to validate CTSB as a prognostic marker in IBC and delineate the mechanisms by which the association of CTSB with cav-1 is involved in lymph node metastasis in IBC patients are in progress. The gene discussed is CTSB; the disease is metastatic malignant neoplasm in the lymph nodes.